ClpB levels correlated with ED symptom severity, anti-ClpB antibodies, and anti-α-MSH antibodies, supporting a potential link between bacterial ClpB and the pathophysiology of EDs (Breton et al., 2016). Here, CLPB is linked to Ehlers-Danlos syndrome.